Event

Evaxion Biotech A/S (EVAX)

Evaxion Biotech A/S (EVAX) Files Form 6-K

Business News

Merck & Company Inc (MRK)

Merck’s Enlicitide Decanoate, an Investigational Oral PCSK9 Inhibitor, Significantly Reduced LDL-C in Adults with Heterozygous Familial Hypercholesterolemia (HeFH) in Phase …

SEC News

NLS Pharmaceutics Ltd. (NLSPW)

New Form SCHEDULE 13G - NewcelX Ltd. Filed: 2025-11-07 AccNo: 0001213900-25-107789 Size: 14 KB


Company Report

MAIA Biotechnology Inc. (MAIA)

Understanding Clinical Trials - Part 1 of 2

FDA Approval

ASCENT PHARMS INC

FDA approve SODIUM OXYBATE

About Us

The main activity of our team is the prompt receipt of open information from various sources in order to analyze the market reaction to this information.

Our strategies:

  • a combination of various open sources of information with the identification and use of those that provide information most quickly;
  • extracting information mainly by automatic means using artificial intelligence;
  • providing users with structured information with modern available development tools;
  • the use of approaches and tools of machine learning methods to identify the most important events that affect the market;